NFA
EPZM

Nationwide Fund Advisors’s Epizyme, Inc EPZM Stock Holding History

Nationwide Fund Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-43,274
Closed -$824K – 2449
2017
Q3 		$824K Hold
43,274
– – ﹤0.01% 1915
2017
Q2 		$653K Hold
43,274
– – ﹤0.01% 2035
2017
Q1 		$742K Sell
43,274
-1,604
-4% -$21.4K ﹤0.01% 1931
2016
Q4 		$543K Sell
44,878
-1,278
-3% -$13.3K ﹤0.01% 2141
2016
Q3 		$454K Buy
46,156
+20,000
+76% +$183K ﹤0.01% 2224
2016
Q2 		$268K Hold
26,156
– – ﹤0.01% 2468
2016
Q1 		$317K Buy
26,156
+6,818
+35% +$69K ﹤0.01% 2310
2015
Q4 		$310K Buy
19,338
+578
+3% +$8.57K ﹤0.01% 2339
2015
Q3 		$241K Hold
18,760
– – ﹤0.01% 2473
2015
Q2 		$450K Buy
18,760
+8,774
+88% +$169K ﹤0.01% 2307
2015
Q1 		$188K Buy
9,986
+284
+3% +$5.87K ﹤0.01% 2725
2014
Q4 		$183K Sell
9,702
-183
-2% -$4.28K ﹤0.01% 2679
2014
Q3 		$268K Buy
9,885
+110
+1% +$3.42K ﹤0.01% 2554
2014
Q2 		$304K Buy
9,775
+4,608
+89% +$109K ﹤0.01% 2530
2014
Q1 		$118K Buy
5,167
+556
+12% +$16.9K ﹤0.01% 2698
2013
Q4 		$96K Sell
4,611
-88
-2% -$2.55K ﹤0.01% 2968
2013
Q3 		$189K Buy
4,699
+2,811
+149% +$95.2K ﹤0.01% 2687
2013
Q2 		$53K Buy
+1,888
New +$48.5K ﹤0.01% 2948

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Nationwide Fund Advisors's EPZM Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Epizyme, Inc (EPZM) in Q4 2017, closing a stake of 43,274 shares — an estimated $824K sold.

Nationwide Fund Advisors first reported a position in EPZM in Q2 2013 and held it in 18 quarters. The position peaked at $824K in Q3 2017. 101 funds tracked by Wall St. Rank hold EPZM as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Epizyme, Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 43,274 Epizyme, Inc shares in Q4 2017, an estimated $824K.
  • Nationwide Fund Advisors first reported a position in Epizyme, Inc in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Epizyme, Inc position peaked at $824K in Q3 2017.
  • 101 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.